Works matching AU Hye Jin Kang

Results: 119
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-883
    By:
    • Seung Tae Kim;
    • Yong Sang Hong;
    • Ho Yeong Lim;
    • Jeeyun Lee;
    • Tae Won Kim;
    • Kyu-Pyo Kim;
    • Sun Young Kim;
    • Ji Yeon Baek;
    • Jee Hyun Kim;
    • Keun-Wook Lee;
    • Ik-Joo Chung;
    • Sang-Hee Cho;
    • Kyung Hee Lee;
    • Sang Joon Shin;
    • Hye Jin Kang;
    • Dong Bok Shin;
    • Jae Won Lee;
    • Sook Jung Jo;
    • Young Suk Park
    Publication type:
    Article
    12

    S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial.

    Published in:
    BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-883
    By:
    • Seung Tae Kim;
    • Yong Sang Hong;
    • Ho Yeong Lim;
    • Jeeyun Lee;
    • Tae Won Kim;
    • Kyu-Pyo Kim;
    • Sun Young Kim;
    • Ji Yeon Baek;
    • Jee Hyun Kim;
    • Keun-Wook Lee;
    • Ik-Joo Chung;
    • Sang-Hee Cho;
    • Kyung Hee Lee;
    • Sang Joon Shin;
    • Hye Jin Kang;
    • Dong Bok Shin;
    • Jae Won Lee;
    • Sook Jung Jo;
    • Young Suk Park
    Publication type:
    Article
    13
    14

    Clinical outcomes and prognostic factors inpatients with breast diffuse large B cell lymphoma;Consortium for Improving Survival of Lymphoma(CISL) study.

    Published in:
    BMC Cancer, 2010, v. 10, p. 321, doi. 10.1186/1471-2407-10-321
    By:
    • Ho-Young Yhim;
    • Hye Jin Kang;
    • Yoon Hee Choi;
    • Seok Jin Kim;
    • Won Seog Kim;
    • Yee Soo Chae;
    • Jin Seok Kim;
    • Chul Won Choi;
    • Sung Yong Oh;
    • Hyeon Seok Eom;
    • Jeong-A Kim;
    • Jae Hoon Lee;
    • Jong-Ho Won;
    • Hyeok Shim;
    • Je-Jung Lee;
    • Hwa Jung Sung;
    • Hyo Jung Kim;
    • Dae Ho Lee;
    • Cheolwon Suh;
    • Jae-Yong Kwak
    Publication type:
    Article
    15

    Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non‐Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma.

    Published in:
    Transplant International, 2020, v. 33, n. 10, p. 1211, doi. 10.1111/tri.13664
    By:
    • Kim, Kyoung Ha;
    • Kim, Won Seog;
    • Kim, Seok Jin;
    • Yoon, Dok Hyun;
    • Suh, Cheolwon;
    • Kang, Hye Jin;
    • Choi, Chul Won;
    • Lee, Ho Sup;
    • Bae, Sung Hwa;
    • Park, Jinny;
    • Park, Eun Kyung;
    • Kwak, Jae‐Yong;
    • Lee, Mark Hong;
    • Kang, Byung Woog;
    • Park, Sung‐Kyu;
    • Won, Jong‐Ho
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study.

    Published in:
    BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/245247
    By:
    • Ki-Seong Eom;
    • Seok Jin Kim;
    • Je-Jung Lee;
    • Cheolwon Suh;
    • Jin Seok Kim;
    • Sung-Soo Yoon;
    • Byung Soo Kim;
    • Hye Jin Kang;
    • Young Jin Choi;
    • Chul Soo Kim;
    • Yang Soo Kim;
    • Jae-Yong Kwak;
    • Yoo Jin Kim;
    • Young Don Joo;
    • Yeung-Chul Mun;
    • Deog Yeon Jo;
    • Joon Seong Park;
    • Chi-Young Park;
    • Sung-Hyun Kim;
    • Chang-Ki Min
    Publication type:
    Article
    22

    Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study.

    Published in:
    Acta Oncologica, 2012, v. 51, n. 4, p. 528, doi. 10.3109/0284186X.2011.636753
    By:
    • Kang, Hye Jin;
    • Ryu, Min-Hee;
    • Kim, Kyoung-Mee;
    • Park, Young Soo;
    • Choi, Jene;
    • Ryoo, Baek-Yeol;
    • Kim, Woo Ho;
    • Im, Seock-Ah;
    • Bang, Yung-Jue;
    • Park, Se Hoon;
    • Lee, Jae-Hyuk;
    • Chung, Ik Joo;
    • Bae, Han-Ik;
    • Kim, Jong Gwang;
    • Lee, Kyung Hee;
    • Song, Hong Suk;
    • Kwon, Hyuk-Chan;
    • Baek, Jin Ho;
    • Shin, Dong Bok;
    • Lee, Kyoung Eun
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    Structural insights into the human niacin receptor HCA2-G<sub>i</sub> signalling complex.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37177-6
    By:
    • Yang, Yang;
    • Kang, Hye Jin;
    • Gao, Ruogu;
    • Wang, Jingjing;
    • Han, Gye Won;
    • DiBerto, Jeffrey F.;
    • Wu, Lijie;
    • Tong, Jiahui;
    • Qu, Lu;
    • Wu, Yiran;
    • Pileski, Ryan;
    • Li, Xuemei;
    • Zhang, Xuejun Cai;
    • Zhao, Suwen;
    • Kenakin, Terry;
    • Wang, Quan;
    • Stevens, Raymond C.;
    • Peng, Wei;
    • Roth, Bryan L.;
    • Rao, Zihe
    Publication type:
    Article
    29
    30

    Bortezomib-Melphalan-Prednisone (VMP) Versus MP as Initial Treatment for Very Elderly Patients With Newly Diagnosed Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e70, doi. 10.1016/j.clml.2017.03.126
    By:
    • Kim, Min Kyoung;
    • Kim, Kihyun;
    • Yoon, Do Hyun;
    • Suh, Cheolwon;
    • Moon, Joon Ho;
    • Lee, Yoo Jin;
    • Lee, Jae Hoon;
    • Jung, Sung-Hoon;
    • Lee, Je-Jung;
    • Kim, Hyo Jung;
    • Bae, Sung Hwa;
    • Kim, Jin Seok;
    • Lee, Jeong-Ok;
    • Eom, Hyeon Seok;
    • Lee, Won-Sik;
    • Kang, Hye Jin;
    • Mun, Yeung-Chul;
    • Do, Young Rok;
    • Hyun, Myung Soo
    Publication type:
    Article
    31

    Phase 2 Study Using Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma; Final Analysis (KMM150).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e73, doi. 10.1016/j.clml.2017.03.133
    By:
    • Lee, Je-Jung;
    • Jung, Sung-Hoon;
    • Kim, Kihyun;
    • Kim, Jin Seok;
    • Eom, Hyeon Seok;
    • Min, Chang Ki;
    • Moon, Joon Ho;
    • Sohn, Sang Kyun;
    • Park, Yong;
    • Lee, Ho Sup;
    • Kim, Sung-Hyun;
    • Shin, Ho-Jin;
    • Joo, Young Don;
    • Yoon, Sung-Soo;
    • Park, Seong Kyu;
    • Kwak, Jae-Young;
    • Kang, Hye Jin;
    • Choi, Yunsuk;
    • Mun, Yeung-Chul;
    • Lee, Jae Hoon
    Publication type:
    Article
    32
    33

    Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.

    Published in:
    Cancer Science, 2010, v. 101, n. 11, p. 2443, doi. 10.1111/j.1349-7006.2010.01698.x
    By:
    • Oh, Sung Yong;
    • Kim, Won Seog;
    • Kim, Jin Seok;
    • Kim, Seok Jin;
    • Lee, Suee;
    • Lee, Dae Ho;
    • Won, Jong-Ho;
    • Hwang, In Gyu;
    • Kim, Min Kyoung;
    • Lee, Soon Il;
    • Chae, Yee Soo;
    • Yang, Deok-Hwan;
    • Kang, Hye Jin;
    • Choi, Chul Won;
    • Park, Jinny;
    • Kim, Hyo Jung;
    • Kwon, Jung Hye;
    • Lee, Ho Sup;
    • Lee, Gyeong-Won;
    • Eom, Hyeon Seok
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation.

    Published in:
    Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1230629
    By:
    • Seok Jin Kim;
    • Jae-Cheol Jo;
    • Dok Hyun Yoon;
    • Deok-Hwan Yang;
    • Sang Eun Yoon;
    • Gyeong-Won Lee;
    • Jee Hyun Kong;
    • Yong Park;
    • Ka-Won Kang;
    • Ho-Sup Lee;
    • Sung Yong Oh;
    • Ho-Jin Shin;
    • Won Sik Lee;
    • Yoon Seok Choi;
    • Seong Hyun Jeong;
    • Min Kyoung Kim;
    • Hye Jin Kang;
    • Jun Ho Yi;
    • Sung-Nam Lim;
    • Ho-Young Yhim
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50